Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179335 · ClinicalTrials.gov registry record
Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults
A clinical trial, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 45
- Enrollment target
NCT00179335: Completed study, sponsored by Albert Einstein College of Medicine.
NCT00179335 is a clinical trial that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179335 has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
HIV infected patients, aged \</= 35 years and aged \>/= 55 years, who are regularly taking either efavirenz (EFV) or lopinavir/ritonavir (Lop/r) as part of their antiretroviral regimen are being asked to spend 12 hours at the researchers' clinic (the ACS clinic at Jacobi Medical Center, Bronx, New York) for an intensive pharmacokinetic study in which 5 cc of blood will be drawn 9 times over a 12 hour period. Patients taking EFV will return for one additional blood draw the following day.
Interventions
- PROCEDURE Blood drawing to determine drug levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-08 |
| Est. Completion | 2006-09 |
What the finished NCT00179335 record still lists
NCT00179335 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood drawing to determine drug levels is the first listed.
NCT00179335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00179335 about?
NCT00179335 is a clinical study titled "Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults". HIV infected patients, aged \</= 35 years and aged \>/= 55 years, who are regularly taking either efavirenz (EFV) or lopinavir/ritonavir (Lop/r) as part of their antiretroviral regimen are being asked to spend 12 hours at the researchers' clinic (the ACS clinic at Jacobi Medical Center, Bronx, New Y...
What is the current status of trial NCT00179335?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2003-08. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00179335?
The interventions under investigation include: Blood drawing to determine drug levels (PROCEDURE).
Who is sponsoring clinical trial NCT00179335?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia